Partners

#NewAseBioMember | "It is the main meeting point for the biotech ecosystem in Spain, connecting companies, boosting the sector’s visibility, and acting as a key interlocutor with institutions and the market"

Meet AllBiotech, our new member. We spoke with Pablo Goñi, CEO.

CEO Pablo Goñi AllBiotech
AseBio
Corporate

AseBio. What does your company contribute and what is its main strength?
Pablo Goñi. AllBiotech provides accessible and versatile solutions for bioprocess development, enabling startups, technology centers, and universities to scale their projects without major investments. Our strength lies in combining simplicity, flexibility, and cost-effective laboratory equipment with a very close customer-oriented approach.

AseBio. What does AseBio mean to you?
Pablo Goñi. It is the main meeting point for the biotech ecosystem in Spain, connecting companies, boosting the sector’s visibility, and acting as a key interlocutor with institutions and the market.

AseBio. When did you first hear about AseBio?
Pablo Goñi. From the very early stages of the company’s development, while analyzing the national biotech ecosystem and the key players shaping it.

AseBio. What do you expect from being part of an association like AseBio?
Pablo Goñi. Visibility within the sector, access to high-quality networking, collaboration opportunities, and staying aligned with the real trends and needs of the biotech ecosystem.

AseBio. What is the biggest challenge facing the biotech sector or your company?
Pablo Goñi. Bringing intelligence to bioreactors and reducing the gap between research and market: enabling the technological and economic scalability of biotech developments so they can reach industrial application faster and more effectively.